Jason R Kelly is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 3.89 Million shares of DNA, which is worth approximately $24.3 Million. The most recent transaction as insider was on Jan 26, 2023, when has been sold 251,171 shares (Class A Common Stock) at a price of $1.77 per share, resulting in proceeds of $444,572. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.89M
0% 3M change
43.51% 12M change
Total Value Held $24.3 Million

Jason R Kelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2023
SELL
Open market or private sale
$444,572 $1.77 p/Share
251,171 Reduced 1.68%
14,695,869 Class A Common Stock
Jan 25 2023
SELL
Open market or private sale
$447,634 $1.73 p/Share
258,748 Reduced 1.7%
14,947,040 Class A Common Stock
Jan 24 2023
SELL
Open market or private sale
$280,269 $1.82 p/Share
153,994 Reduced 1.0%
15,205,788 Class A Common Stock
Jan 23 2023
SELL
Open market or private sale
$251,662 $1.75 p/Share
143,807 Reduced 0.93%
15,359,782 Class A Common Stock
Jan 20 2023
SELL
Open market or private sale
$254,182 $1.67 p/Share
152,205 Reduced 0.97%
15,503,589 Class A Common Stock
Jan 19 2023
SELL
Open market or private sale
$445,728 $1.7 p/Share
262,193 Reduced 1.65%
15,655,794 Class A Common Stock
Jan 18 2023
SELL
Open market or private sale
$494,304 $1.94 p/Share
254,796 Reduced 1.58%
15,917,987 Class A Common Stock
Jan 17 2023
SELL
Open market or private sale
$281,847 $1.86 p/Share
151,531 Reduced 0.93%
16,172,783 Class A Common Stock
Jan 13 2023
SELL
Open market or private sale
$278,999 $1.77 p/Share
157,627 Reduced 0.96%
16,324,314 Class A Common Stock
Jan 12 2023
SELL
Open market or private sale
$434,631 $1.72 p/Share
252,693 Reduced 1.51%
16,481,941 Class A Common Stock
Jan 11 2023
SELL
Open market or private sale
$399,247 $1.62 p/Share
246,449 Reduced 1.45%
16,734,634 Class A Common Stock
Jan 10 2023
SELL
Open market or private sale
$236,697 $1.5 p/Share
157,798 Reduced 0.92%
16,981,083 Class A Common Stock
Jan 09 2023
SELL
Open market or private sale
$231,281 $1.52 p/Share
152,159 Reduced 0.88%
17,138,881 Class A Common Stock
Jan 06 2023
SELL
Open market or private sale
$226,620 $1.49 p/Share
152,094 Reduced 0.87%
17,291,040 Class A Common Stock
Jan 05 2023
SELL
Open market or private sale
$376,562 $1.54 p/Share
244,521 Reduced 1.38%
17,443,134 Class A Common Stock
Jan 04 2023
SELL
Open market or private sale
$155,000 $1.55 p/Share
100,000 Reduced 0.56%
17,687,655 Class A Common Stock
Dec 23 2022
SELL
Open market or private sale
$333,492 $1.64 p/Share
203,349 Reduced 1.13%
17,787,655 Class A Common Stock
Dec 22 2022
SELL
Open market or private sale
$347,579 $1.66 p/Share
209,385 Reduced 1.15%
17,991,004 Class A Common Stock
Dec 21 2022
SELL
Open market or private sale
$328,458 $1.7 p/Share
193,211 Reduced 1.05%
18,200,389 Class A Common Stock
Dec 20 2022
SELL
Open market or private sale
$678,553 $1.66 p/Share
408,767 Reduced 2.17%
18,393,600 Class A Common Stock
Dec 19 2022
SELL
Open market or private sale
$344,769 $1.67 p/Share
206,449 Reduced 1.09%
18,802,367 Class A Common Stock
Dec 16 2022
SELL
Open market or private sale
$162,281 $1.6 p/Share
101,426 Reduced 0.53%
19,008,816 Class A Common Stock
Dec 15 2022
SELL
Open market or private sale
$166,710 $1.61 p/Share
103,547 Reduced 0.54%
19,110,242 Class A Common Stock
Dec 14 2022
SELL
Open market or private sale
$172,963 $1.69 p/Share
102,345 Reduced 0.53%
19,213,789 Class A Common Stock
Dec 13 2022
SELL
Open market or private sale
$186,985 $1.89 p/Share
98,934 Reduced 0.51%
19,316,134 Class A Common Stock
JRK

Jason R Kelly

Director
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA